Sarah has worked in pharmacovigilance at the UK’s Medicines and Healthcare products Regulatory Agency for the past 20 years. Her current role is the Head of Vigilance Operations, responsible for adverse incident management & signal management processes for medicines, vaccines and medical devices. Sarah’s recent work has focussed on leading the development and transformation of the Agency’s vigilance systems for all medicinal product types and engaging with strategic stakeholders across the UK healthcare system for adverse incident data collection and signal management processes.